FR2422624A1 - NEW ANTICHOLINERGIC AGENTS WITH ANTI-SECRETORY ACTIVITY, THEIR PREPARATION PROCESS AND THEIR USES - Google Patents

NEW ANTICHOLINERGIC AGENTS WITH ANTI-SECRETORY ACTIVITY, THEIR PREPARATION PROCESS AND THEIR USES

Info

Publication number
FR2422624A1
FR2422624A1 FR7835596A FR7835596A FR2422624A1 FR 2422624 A1 FR2422624 A1 FR 2422624A1 FR 7835596 A FR7835596 A FR 7835596A FR 7835596 A FR7835596 A FR 7835596A FR 2422624 A1 FR2422624 A1 FR 2422624A1
Authority
FR
France
Prior art keywords
preparation process
anticholinergic agents
secretory activity
new anticholinergic
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7835596A
Other languages
French (fr)
Other versions
FR2422624B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INTER RESEARCH CORP
Original Assignee
INTER RESEARCH CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INTER RESEARCH CORP filed Critical INTER RESEARCH CORP
Publication of FR2422624A1 publication Critical patent/FR2422624A1/en
Application granted granted Critical
Publication of FR2422624B1 publication Critical patent/FR2422624B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/90—Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Les médicaments selon l'invention présentent une activité anticholinergique et antisécrétoire et répondant aux formules générales :The medicaments according to the invention exhibit anticholinergic and antisecretory activity and meet the general formulas:

FR7835596A 1977-12-16 1978-12-18 NEW ANTICHOLINERGIC AGENTS WITH ANTI-SECRETORY ACTIVITY, THEIR PREPARATION PROCESS AND THEIR USES Granted FR2422624A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86121077A 1977-12-16 1977-12-16

Publications (2)

Publication Number Publication Date
FR2422624A1 true FR2422624A1 (en) 1979-11-09
FR2422624B1 FR2422624B1 (en) 1983-10-14

Family

ID=25335183

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7835596A Granted FR2422624A1 (en) 1977-12-16 1978-12-18 NEW ANTICHOLINERGIC AGENTS WITH ANTI-SECRETORY ACTIVITY, THEIR PREPARATION PROCESS AND THEIR USES

Country Status (15)

Country Link
JP (1) JPS5498711A (en)
AR (1) AR222478A1 (en)
AT (1) AT366380B (en)
AU (1) AU531835B2 (en)
CA (1) CA1102345A (en)
DE (1) DE2854308A1 (en)
DK (1) DK534178A (en)
ES (1) ES476048A1 (en)
FR (1) FR2422624A1 (en)
GB (1) GB2010270B (en)
IE (1) IE48012B1 (en)
IT (1) IT1101735B (en)
NL (1) NL7812257A (en)
NO (1) NO148776C (en)
SE (1) SE436027B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045055A1 (en) * 1980-11-29 1982-07-01 Celamerck Gmbh & Co Kg, 6507 Ingelheim HETEROCYCLIC COMPOUNDS
JPS5993075A (en) * 1982-11-18 1984-05-29 Shionogi & Co Ltd Preparation of 1-phthalidyl-5-fluorouracil derivative
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
FR2703046B1 (en) * 1993-03-26 1995-05-05 Poudres & Explosifs Ste Nale Process for the preparation of alpha-monohalogenated oxalates and haloglyoxalates and new alpha-monohalogenated oxalates and haloglyoxalates.
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
AR044134A1 (en) 2003-05-02 2005-08-24 Novartis Ag DERIVATIVES OF QUINUCLIDINE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS.
JP5401092B2 (en) 2005-06-03 2014-01-29 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド Methods and compositions for transdermal drug delivery
KR20080089461A (en) * 2005-12-30 2008-10-06 랜박시 래보러터리스 리미티드 Muscarinic receptor antagonists
EA019760B1 (en) 2007-11-02 2014-06-30 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи Transdermal delivery system, method for transdermal administration and method of preparing transdermal delivery system
CN110526864A (en) * 2012-10-05 2019-12-03 斯菲拉制药私人有限公司 New compound, its synthesis and application thereof
DE102013013397A1 (en) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosol dispenser for transdermal pharmaceutical compositions
CN110041264A (en) * 2019-04-11 2019-07-23 贺州学院 A kind of adamantyl glyoxaline ion liquid and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH347842A (en) * 1955-03-19 1960-07-31 Boehringer Sohn Ingelheim Process for the preparation of quaternary aminoalkyl esters of organic acids
JPS506465A (en) * 1973-04-16 1975-01-23
FR2276289A1 (en) * 1974-06-24 1976-01-23 Inter Research Corp QUATERNARY AMMONIUM SALTS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH347842A (en) * 1955-03-19 1960-07-31 Boehringer Sohn Ingelheim Process for the preparation of quaternary aminoalkyl esters of organic acids
JPS506465A (en) * 1973-04-16 1975-01-23
FR2276289A1 (en) * 1974-06-24 1976-01-23 Inter Research Corp QUATERNARY AMMONIUM SALTS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1975 *

Also Published As

Publication number Publication date
NO148776B (en) 1983-09-05
SE436027B (en) 1984-11-05
IE48012B1 (en) 1984-09-05
AU531835B2 (en) 1983-09-08
NO148776C (en) 1983-12-14
ATA901478A (en) 1981-08-15
FR2422624B1 (en) 1983-10-14
JPS5498711A (en) 1979-08-03
CA1102345A (en) 1981-06-02
NO784229L (en) 1979-06-19
NL7812257A (en) 1979-06-19
AU4264678A (en) 1979-06-21
IE782499L (en) 1979-06-16
DK534178A (en) 1979-06-17
IT7830735A0 (en) 1978-12-12
DE2854308A1 (en) 1979-06-21
GB2010270B (en) 1982-10-20
IT1101735B (en) 1985-10-07
SE7812911L (en) 1979-06-17
GB2010270A (en) 1979-06-27
AT366380B (en) 1982-04-13
AR222478A1 (en) 1981-05-29
ES476048A1 (en) 1979-11-01

Similar Documents

Publication Publication Date Title
IT7928464A0 (en) PHARMACEUTICAL COMPOSITION HAVING ANTI-CANCER ACTIVITY.
FR2422624A1 (en) NEW ANTICHOLINERGIC AGENTS WITH ANTI-SECRETORY ACTIVITY, THEIR PREPARATION PROCESS AND THEIR USES
DE3063541D1 (en) Process for the preparation of 4'-epidaunorubicin, 3',4'-diepidaunorubicin, intermediates created thereby, as well as their use
IT1164097B (en) "1,4-DI HYDROPYRIDINE THEIR PREPARATION AND THEIR APPLICATION AS MEDICATIONS"
FR2387980A1 (en) NEW 2- (2,2-DIARYLALKYL) -1-AZABICYCLO (2.2.2) OCTANES, USEFUL IN PARTICULAR AS ANTIDIARRHEA, AND THEIR PREPARATION PROCESS
IT8023058A0 (en) 1,9-DIHYDROXYOCTAHYDROBENZO [C]QUINOLINES AND 1-HYDROXYHEXHAYDROBENZO [C]QUINOLIN-9(8H)-ONI AS ANTIEMETIC AGENTS
FR2446283A1 (en) PHENOXYPHENYLPIPERIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS
FR2390446A1 (en) NEW TRIAZINES 1,3,5-S-HEXAHYDROTRISUBSTITUESES, THEIR PREPARATION AND THEIR APPLICATION TO THE FIGHT AGAINST MICROBIAL DEVELOPMENT
DK240979A (en) 3-AZABICYCLO (3,1,0) HEXANDERIVATIVES
FR2533920B1 (en) TRIPEPTIDE- AND TETRAPEPTIDE-ALKYLAMIDES WITH BIOLOGICAL ACTIVITY, USEFUL AS MEDICAMENTS AND METHODS FOR THEIR PREPARATION
FR2421900A1 (en) PIPERAZINO-3-INDOLES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATIONS
FR2422658A1 (en) PIPERAZINYL-BENZOHETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
TR20548A (en) 1,2,3-TIYADIYAZEL-5-YEAR MEMBERS 'IMALLINE SPECIFIC PROCEDURE
FR2403994A1 (en) NEWS 1- (2-CHLOROETHYL) -1-NITROSOUREES USEFUL IN PARTICULAR AS ANTITUMOR AGENTS AND THEIR PREPARATION PROCESS
OA06326A (en) Composition fungicides and their preparation.
IT8447964A1 (en) COMPLEXES OF INCLUSION, THEIR PREPARATION AND THEIR USE AS INSECTICIDES.
BE880509A (en) PROCESS FOR THE PREPARATION OF 2 ', 6'-DIALKYL-N-ALCOXYMETHYL-2-CHLORO-ACETANILIDES
JPS577469A (en) Manufacture of 2,3,5-trichloropyridine
FR2376135A1 (en) AMINOETHOXY-3 PYRROLIDINES SUBSTITUTED IN POSITION 1, USEFUL AS MEDI
FR2372792A1 (en) AMINOALCOXYBENZENES, THEIR PREPARATION AND THEIR THERAPEUTIC USES
FR2415620A1 (en) 6/7-HALOGENO-ANTHRAQUINONIC COMPOUNDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION
FR2433516A1 (en) PYRIDOXINS, THEIR PREPARATION AND THEIR THERAPEUTIC USES
BE878577A (en) SUBSTITUTED AMINOALKYLGUANIDINES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
FR2377406A1 (en) TETRATHIAPENTALENE AND TETRASELENAPENTALENE COMPOUNDS
IT7819905A0 (en) PYRIMIDYLSULPHIDES WITH ANTI-SECRETORY ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse